N/A N=16 Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
Primary Open Angle Glaucoma
Primary: Blood Oxygenation — 60; 60; 60 percentage of oxygenation
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=344 Identifying Factors That Predict Antidepressant Treatment Response
Depression
Primary: Remission From Major Depressive Episode in Intent to Treat Sample — 46.7; 54.7; 41.9 percentage of participants
Phase 3 N=96 A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis
Anemia
Primary: Percentage of Participants Who Maintained Average Hb Value Within Target Range During the EEP — 50.0 percentage of participants
N/A N=8 Identification of Optimal Stimulation Site for Cervical Dystonia Symptoms: An Exploratory Study
Cervical Dystonia · Spasmodic Torticollis
Primary: Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) — -3.0; 0.25; -2.9; -1.5 units on a scale
N/A N=5 Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
Lung Cancer · Prostate Cancer · Bladder Cancer
Primary: Number of Participants to Achieve Saturation in an English-language Paper Questionnaire — 30 participants
Phase 4 N=55 Surgical Pain Control With Ropivacaine by Atomized Delivery
Pain
Primary: Post-op Pain With Atomized Intraperitoneal Ropivacaine (AIR) — 2.536; 3.844 millimeters — p=.098
Phase 2 N=48 Phase II Bevacizumab, Gemcitabine and Carboplatin in Newly Diagnosed Non-Small Cell Lung Cancer
Lung Cancer · Non-small Cell Lung Cancer (NSCLC)
Primary: Progression-free Survival (PFS) — 8.7 months
Phase 4 N=20 Post-Market Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (CF-EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
Atrial Fibrillation
Primary: Acute Isolation of Pulmonary Veins. — 99 percent isolated pulmonary veins
N/A N=11 Effect of Three Fibres on Glycaemic and Insulinaemic Responses in Healthy Adult Volunteers
Healthy Volunteers
Primary: Assessment of IAUC (Incremental Area Under the Curve) in Blood Glucose Response — 127.45; 143.53; 19.27; 134.21 min*mmol/L
N/A N=1,005 Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)
Coronary Arteriosclerosis
Primary: Major Adverse Cardiac Events — 67; 91 participants
N/A N=32 Appetite Suppression Trial With Polydextrose
Body Weight · Non-restrained Eaters
Primary: Energy Intake at an ad Libitum Lunch on a Test-day in Normal Weight and Overweight Women. — 2694; 2537; 2317; 2335 kJ — p=0.2918
N/A N=29 Intra Oral Kinetics of Fluoride Containing Dentifrices
Tooth Erosion
Primary: Concentrations of Fluoride Ions in Saliva 60 Minutes Post Brushing Prior to Administration of the Orange Juice or De-ionised Water Rinse — 0.23; 0.23; 0.15 parts per…
Phase 2 N=5 Islet Transplantation Using Abatacept
Type 1 Diabetes Mellitus
Primary: The Number of Insulin-independent Subjects at Day 75 (± 5 Days) Following the First Islet Cell Transplantation — 4; 1 participants
Phase 2 N=100 Clinical Study of the CardioFocus Endoscopic Ablation System - Adaptive Contact (EAS-AC) for the Treatment of Symptomatic Atrial Fibrillation
Paroxysmal Atrial Fibrillation
Primary: Freedom From Recurrence of Atrial Fibrillation — 50 successful participants
N/A N=96 Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy
Cardiac Allograft Vasculopathy
Primary: Cardiac Allograft Vasculopathy(CAV) Defined as Change in IVUS-assessed Plaque Volume From Baseline to One Year — 3.39; 3.65 mm3/mm